Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Nagata

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
The American Journal of Gastroenterology|January 13, 2006
A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcomaKeiji Hirata, Shuichi Kanemitsu, Yoshifumi Nakayama, et al.
BMC Bioinformatics|December 1, 2006
Automatic recognition of topic-classified relations between prostate cancer and genes using MEDLINE abstractsHong-Woo Chun, Yoshimasa Tsuruoka, Jin-Dong Kim, et al.
Oncology Letters|January 25, 2019
A multicenter single-arm Phase II clinical trial of second-line FOLFIRI plus panitumumab after first-line treatment with FOLFOX plus panitumumab for initial <i>RAS</i> wild-type colorectal cancer with evaluation of circulating tumor DNA: A protocol studyHiromichi Maeda, Naoki Nagata, Takeshi Nagasaka, et al.
Anticancer Research|December 27, 2011
Multi-center phase II study of FLOX for advanced colorectal cancer patients in Japan: SWIFT 3 studyTakeshi Kato, Naoki Nagata, Makoto Fujii, et al.
Journal of UOEH|December 13, 2021
[A Case of Ascending Colon Cancer with Skull Metastasis]Atsushi Toyofuku, Rina Torii, Masaru Idei, et al.
Journal of UOEH|March 30, 2005
[Two cases of nonrecurrent inferior laryngeal nerve--different branching levels from vagus nerve]Tetsumi Konishi, Asami Fukushima, Shu Watanabe, et al.
Anticancer Research|June 30, 2016
Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer -The PHOENiX TrialTakanori Matsui, Naoki Nagata, Keiji Hirata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 23, 2023
[Re-Administration of Anti-EGFR Antibody Drugs for Unresectable Colorectal Cancer-Focusing on Tumor Markers]Ryota Murayama, Akiko Sakurai, Kohei Yoshida, et al.
Anticancer Research|June 17, 2009
Chemopreventive effect of 4-[3,5-Bis(trimethylsilyl) benzamido] benzoic acid (TAC-101) on MNU-induced colon carcinogenesis in a rat modelYoshifumi Nakayama, Yuzuru Inoue, Noritaka Minagawa, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2015
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositisChu Matsuda, Yoshinori Munemoto, Hideyuki Mishima, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
The American Journal of Gastroenterology|January 13, 2006
A novel germline mutation of MSH2 in a hereditary nonpolyposis colorectal cancer patient with liposarcomaKeiji Hirata, Shuichi Kanemitsu, Yoshifumi Nakayama, et al.
BMC Bioinformatics|December 1, 2006
Automatic recognition of topic-classified relations between prostate cancer and genes using MEDLINE abstractsHong-Woo Chun, Yoshimasa Tsuruoka, Jin-Dong Kim, et al.
Oncology Letters|January 25, 2019
A multicenter single-arm Phase II clinical trial of second-line FOLFIRI plus panitumumab after first-line treatment with FOLFOX plus panitumumab for initial <i>RAS</i> wild-type colorectal cancer with evaluation of circulating tumor DNA: A protocol studyHiromichi Maeda, Naoki Nagata, Takeshi Nagasaka, et al.
Anticancer Research|December 27, 2011
Multi-center phase II study of FLOX for advanced colorectal cancer patients in Japan: SWIFT 3 studyTakeshi Kato, Naoki Nagata, Makoto Fujii, et al.
Journal of UOEH|December 13, 2021
[A Case of Ascending Colon Cancer with Skull Metastasis]Atsushi Toyofuku, Rina Torii, Masaru Idei, et al.
Journal of UOEH|March 30, 2005
[Two cases of nonrecurrent inferior laryngeal nerve--different branching levels from vagus nerve]Tetsumi Konishi, Asami Fukushima, Shu Watanabe, et al.
Anticancer Research|June 30, 2016
Bi-weekly Capecitabine-Oxaliplatin (XELOX) plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer -The PHOENiX TrialTakanori Matsui, Naoki Nagata, Keiji Hirata, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 23, 2023
[Re-Administration of Anti-EGFR Antibody Drugs for Unresectable Colorectal Cancer-Focusing on Tumor Markers]Ryota Murayama, Akiko Sakurai, Kohei Yoshida, et al.
Anticancer Research|June 17, 2009
Chemopreventive effect of 4-[3,5-Bis(trimethylsilyl) benzamido] benzoic acid (TAC-101) on MNU-induced colon carcinogenesis in a rat modelYoshifumi Nakayama, Yuzuru Inoue, Noritaka Minagawa, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2015
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositisChu Matsuda, Yoshinori Munemoto, Hideyuki Mishima, et al.
Pageof 9